These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 3893694)

  • 1. Methotrexate: bioavailability and pharmacokinetics.
    Campbell MA; Perrier DG; Dorr RT; Alberts DS; Finley PR
    Cancer Treat Rep; 1985; 69(7-8):833-8. PubMed ID: 3893694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing.
    Jundt JW; Browne BA; Fiocco GP; Steele AD; Mock D
    J Rheumatol; 1993 Nov; 20(11):1845-9. PubMed ID: 8308768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects.
    Allen A; Down G; Newland A; Reynard K; Rousell V; Salmon E; Scott R
    Clin Ther; 2007 Jul; 29(7):1415-20. PubMed ID: 17825692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampin in the horse: comparison of intravenous, intramuscular, and oral administrations.
    Burrows GE; MacAllister CG; Beckstrom DA; Nick JT
    Am J Vet Res; 1985 Feb; 46(2):442-6. PubMed ID: 3994110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of tiapride and absolute bioavailability of three extravascular forms.
    Rey E; d'Athis P; Richard MO; de Lauture D; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):62-7. PubMed ID: 7061180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate kinetics in rheumatoid arthritis: is there an interaction with nonsteroidal antiinflammatory drugs?
    Ahern M; Booth J; Loxton A; McCarthy P; Meffin P; Kevat S
    J Rheumatol; 1988 Sep; 15(9):1356-60. PubMed ID: 3199396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.
    Mück W; Ritter W; Ochmann K; Unger S; Ahr G; Wingender W; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):255-60. PubMed ID: 9208342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of difloxacin after intravenous, intramuscular, and intragastric administration to horses.
    Fernández-Varón E; Cárceles CM; Marín P; Martos N; Escudero E; Ayala I
    Am J Vet Res; 2006 Jun; 67(6):1076-81. PubMed ID: 16740105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of low-dose methotrexate in adult asthmatics.
    Glynn-Barnhart AM; Erzurum SC; Leff JA; Martin RJ; Cochran JE; Cott GR; Szefler SJ
    Pharmacotherapy; 1992; 12(5):383-90. PubMed ID: 1437699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and bioavailability of metronidazole after tablets, suppositories and intravenous administration.
    Bergan T; Leinebo O; Blom-Hagen T; Salvesen B
    Scand J Gastroenterol Suppl; 1984; 91():45-60. PubMed ID: 6588489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose oral methotrexate.
    McVie JG; Stuart JF; Calman KC; Reid JL
    Cancer Treat Rep; 1981; 65 Suppl 1():141-3. PubMed ID: 7198935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute bioavailability of sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, in healthy volunteers.
    Bergman A; Ebel D; Liu F; Stone J; Wang A; Zeng W; Chen L; Dilzer S; Lasseter K; Herman G; Wagner J; Krishna R
    Biopharm Drug Dispos; 2007 Sep; 28(6):315-22. PubMed ID: 17575559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics.
    Patterson EE; Goel V; Cloyd JC; O'Brien TD; Fisher JE; Dunn AW; Leppik IE
    J Vet Pharmacol Ther; 2008 Jun; 31(3):253-8. PubMed ID: 18471147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian calculation of methotrexate clearance after low dose intramuscular administration in patients with rheumatoid arthritis.
    Monjanel-Mouterde S; Lafforgue P; Blanc A; Catalin J; Aquaviva PC; Durand A
    J Rheumatol; 1998 Jul; 25(7):1276-81. PubMed ID: 9676756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous administration of methotrexate with a prefilled autoinjector pen results in a higher relative bioavailability compared with oral administration of methotrexate.
    Pichlmeier U; Heuer KU
    Clin Exp Rheumatol; 2014; 32(4):563-71. PubMed ID: 24983446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of high-dose methotrexate with citrovorum factor rescue.
    Isacoff WH; Morrison PF; Aroesty J; Willis KL; Block JB; Lincoln TL
    Cancer Treat Rep; 1977 Dec; 61(9):1665-74. PubMed ID: 304376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased intestinal absorption of methotrexate in the rat following repeated oral dosing.
    Sonneveld P; Storm AJ; Nooter K
    Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):133-6. PubMed ID: 3992025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.